北京大學第三醫院

病理科

北京大學第三醫院病理科是國家臨床重點專科，是全國大型的疑難病例病理診斷中心之一。病理科依託於歷史悠久的北京大學醫學部病理系，在幾代病理學工作者的辛勤耕耘和努力開拓下，發展成為教學、科研、臨床相結合的優勢學科。經多年醫療實踐積澱，科室不斷開拓創新以適應日益增長的專科化醫療服務需求。目前形成了包括泌尿病理、血液病理、神經病理、消化病理、呼吸病理、婦科病理、乳腺病理、皮科病理、內分泌病理、軟組織與骨關節病理、細胞學、解剖病理和分子病理等涵蓋人體多個系統的十三個病理亞專科。病理科於2004 年，就成為第一批國家級繼續教育基地；2006 年，首批入選北京市住院醫師規範化培訓臨床病理專科基地；2010 年底，首批入選“國家臨床重點病理專科建設專案”。 病理科擁有一支梯隊合理的專業醫師隊伍，一批國內知名病理學專家。同時，病理科也擁有一個專業的醫技團隊，涵蓋常規病理平臺、免疫組化平臺、特殊染色平臺、超微病理平臺、針吸細胞學平臺和分子病理學平臺等，有力的支援了臨床病理診斷、教學和科研工作。病理科下屬的分子病理實驗室，是我國第一批獲得衛生部臨檢中心認證的臨床基因擴增檢驗實驗室。同時也是國家衛健委病理質控評價中心（PQCC）示範實驗室和北京市重點實驗室。 目前，我科室已發展為年組織學樣本量 9 萬例、細胞學 6.5 萬例、屍體解剖 50例、電鏡 6000 例、會診 7000 例、分子病理檢測 6000 例、集臨床、教學和科研為一體、從大體、光鏡、電鏡觀察到免疫組化、遺傳學檢測的系統化、標準化、數字化和資訊化整合，臨床病理工作水平位於全國領先的綜合學科。 The Department of Pathology of Peking University Third Hospital (Dpt. Path.) is a national key clinical specialty and is one of the large-scale pathological consultation center in China. The Dpt. Path. relies on the Department of Pathology of Peking University Health Science Center. Through the hard working of several generations of pathologists, it has developed into a superior discipline with a combination of teaching, scientific research and clinical service, After years of accumulation of medical practice, the Dpt. Path. continue to innovate to meet the growing demand for specialized medical services. At present, it has formed a series of subspecialties consisting of urological pathology, hematopoietic pathology, neuropathology, gastrointestinal pathology, lung pathology, gynecological pathology, breast pathology, dermatology pathology, endocrine pathology, soft tissue-bone-joint pathology, cytology, anatomical pathology and molecular pathology. The Dpt. Path. became one of the first approved bases for national continuing education in 2004; in 2006, it was pioneered to be the standardized training base for clinical pathology residency in 2010, it was granted as one of the "National Key Clinical Pathology Specialty Construction Project". The Dpt. Path. has a team of professional pathologists with reasonable echelon construction,, and producing a group of well-known domestic experts. The Dpt. Path. also has a professional medical technologists team, covering conventional pathology platform, immunohistochemistry platform, special staining platform, ultrastructuralpathology platform, fine needle aspiration cytology platform and molecular pathology platform, etc., which strongly supports clinical pathological diagnosis, teaching and scientific research. The Molecular Pathology Laboratory affiliated the Dpt. Path. is the first batch of clinical gene amplification testing laboratories certified by the National Center of Ministry of Health for Clinical Laboratories. Meanwhile, this lab is also a demonstration laboratory of the National Pathology Quality Control Center (PQCC) and a key laboratory in Beijing. At present, the Dpt. Path. has an annual histological samples of 90,000 cases, cytology 65,000 cases, autopsy 50 cases, electron microscopy 6,000 cases, consultation 7000 cases and molecular pathology examination 6000 cases. Integrating clinical, teaching and scientific research, the Dpt. Path. is a nationally leading comprehensive department for clinical pathology, from general, light microscope and electron microscope observations to the systematic, standardized, digital and information integration of immunohistochemistry and genetic testing.